ciprofloxacin 7

8/8/2019 Ciprofloxacin 7

1/3

Ciprofloxacin

7

mg IV q12h

Bactericidal;interfereswithDNAreplication insusceptiblebacteria

preventingcellreproduction

Indications:

For the treatment

of infections

caused by

susceptible gram-

negative bacteria

including E. coli,

P.

mirabilis, K.

pneumoniae,

Enterobacter

cloacae, P.

vulgaris, P.rettgeri, M.

morganii, P.

aeruginosa,

Citrobacter

freundii, S.

aureus, S.

epidermidis,group

D streptococc

Contraindications:

Allergy to

ciprofloxacin,

norfloxacin orother

fluoroquinolones,

pregnancy,

lactation

CNS:Headache,

dizziness, insomnia,

fatigue, somnolence,

depression, blurred

vision

CV:Arrhyt hmias

hypotension, angina

EENT: Dry eye, eye pain,

keratopathy

GI:Nausea, vomiting, dry

mouth,diarrhea,

abdominal pain

Hematologic:Elevated

BUN, AST, ALT, serumcreatinine and alkaline

phosphatase;

decreased WBC,

neutrophil count, Hct

Other: Fever, rash

Assess patient

for signs

andsymptoms

ofinfection

Obtain C/S

before

beginnin

drug therapy

Assess for

anaphylaxis

Identify urine

output

Monitor blood

studies

Monitor

electrolytes

Assess bowel

pattern daily

Monitor for

bleeding

Precautions:

Pregnancy,

lactation,

children, renal

disease,

epilepsy

Simvastatin40mg/tab 1

InhibitsHMG-CoA ications Contraindications CNS:Headache,asthenia, Assess


2/3

tab OD at hs(p.o.

reductase,theenzyme thatcatalyzes thefirststep in thecholesterol

synthesispathway,resulting in adecrease inserumcholesterol,serumLDLs, andeitheran increaseor nochange inserumHDLs.

Adjunct to diet in

the treatment of

elevated total

cholestrol and

LDL

cholesterol with

primary

hypercholesterole

mia (types IIa and

IIb) in those

unresponsive to

dietary restriction

of saturated fat

and cholesterol

and othernonpharmacologic

measures

To reduce the risk

of coronary

disease, mortality,

and CV events,

including stroke,

TIA, MI and

reduction in needfor bypass

surgery

and angionplasty

in patients with

coronary heart

disease and

hypercholesterole

mia

Treatment ofpatients with

isolated

hypertriglyceridem

ia mia

Contraindicated

with allergy to

simvastatin,

fungal

byproducts,

pregnancy,

lactation

Treatment of type

III

hyperlipoproteine

sleep disturbances

GI: Flatulence, diarrhea,

abdominal pain,

cramps, constipation,

nausea, dyspepsia,

heartburn, liver failure

Respiratory:Sinusitis,

pharyngitis

Other:Rhabdomyolysis,

acute renal failure,

arthralgia, myalgi

nutrition:

fat, protein,

carbohydrates

Monitor bowel

pattern daily

Monitor

triglycerides,

cholesterol

baseline

throughout

treatment

Precautions:

Past liver

disease,

alcoholism,

severe acute

infections,

trauma,

severe

metabolic

disorders,

electrolyte

imbalances,

elderly, renal

disease


3/3

Treatment of

adolescents 10-

17

yr with

heterozygous

familial

hypercholesterole

mia

ciprofloxacin 7

Documents